Former President and Chief Executive Officer · RHYTHM PHARMACEUTICALS, INC. (RYTM)

Keith Gottesdiener

A named executive officer of RHYTHM PHARMACEUTICALS in every fiscal year CompBrief holds from FY2017 to FY2020. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2020

$3,449,169

Salary $142,906Stock awards $0

FY2019: $4,937,042

2nd of 6 named executive officers at Rhythm Pharmaceuticals by FY2020 total.

6 named officers on file for RHYTHM PHARMACEUTICALS, FY2020

Keith Gottesdiener’s pay file — $29

  • 4 fiscal years of pay, line by line
  • RYTM’s disclosed peer group of 20 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how RHYTHM PHARMACEUTICALS’s whole pay program stands against its peers

  • RHYTHM PHARMACEUTICALS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on RYTM→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 27, 2021 (DEF 14A).

Free

Get Keith Gottesdiener’s full pay file as a PDF — free

More than this page: up to 10 years of Keith’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Keith Gottesdiener compensation by year

RHYTHM PHARMACEUTICALS Summary Compensation Table · all 4 fiscal years held
In US dollars, as RHYTHM PHARMACEUTICALS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2017FY2018FY2019FY2020
Salary$490,795$505,519$525,934$142,906
Bonus$0$0$0$0
Stock awards$0$0$0$0
Option awards$799,994$2,756,250$4,133,768$2,810,726
Non-equity incentive$245,398$278,035$277,340$0
Pension and deferred compensation$0$0$0$0
All other$0$0$0$495,537
Total$1,536,187$3,539,804$4,937,042$3,449,169

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: RHYTHM PHARMACEUTICALS, INC. DEF 14A filed April 27, 2021, accession 0001104659-21-055591, and prior-year filings. Open the filing on EDGAR.

How this page was built: the RHYTHM PHARMACEUTICALS, INC. filed document, accession 0001104659-21-055591. Every figure is read from that document and cited to the page and table it appears in. Filed April 27, 2021.

$1.5M
$3.5M
$4.9M
$3.4M
FY17
FY18
FY19
FY20
SalaryNon-equity incentiveOption awardsAll other

RHYTHM PHARMACEUTICALS’s named executive officers, FY2020

as the company reported each
Named executive officerRoleFY2020 total
David MeekerChief Executive Officer$14,277,367
Keith Gottesdiener · this pageFormer President and Chief Executive Officer$3,449,169
Hunter SmithChief Financial Officer$2,662,468
Murray StewartFormer Chief Medical Officer$2,300,314
Nithya DesikanFormer Chief Commercial Officer$1,943,971
Jennifer ChienExecutive Vice President, Head of North America$1,819,617

The full RHYTHM PHARMACEUTICALS compensation record

free company brief

This page is one person within RHYTHM PHARMACEUTICALS's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the RHYTHM PHARMACEUTICALS proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are RHYTHM PHARMACEUTICALS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Keith Gottesdiener's compensation dossier · One-time report. No refunds.